Clinical-economic analysis of COVID-19 treatment drugs at the stationary level

Abstract

Background A number of health system problems have arisen due to the coronavirus. Apart from these problems, the pharmaceutical sector was not left out either, as prescriptions for new virus treatments were unplanned and purchases were irregular. Aim To carry out an economic analysis of the drugs used in the COVID-19 department of the hospital. Methods For the study we used the clinical-economic methods: ABC/VEN analysis, ATC/DDD methodology and DU90% analysis method. Materials for the study were data on the use of drugs by one of the multidisciplinary hospitals in Armenia in the department of COVID-19. Results The ABC/VEN analysis of the drugs revealed that group A did not have non-essential drugs, and group B had non-essential drugs - 18.75%. The combination of the ABC/VEN and DU90% analysis revealed that the DU90% group lacked non-essential drugs, indicating that the hospital had purchased and used the most vital and essential drugs for the COVID-19 department. Conclusion Based on the results, a recommendation was made and sent to the pharmacist of the hospital, who will take into account these results when planning the purchase of drugs for the next year, aiming to reduce the use of non-essential drugs in the hospital.